8Suppliers
7Customers
1Debt Items
20Related Chains

Organon & Co. Suppliers

TickerNameConfidenceEvidence
SEBELA-PHARMACEUTICALS SEBELA-PHARMACEUTICALS 92% On February 19, 2026, Organon entered into an exclusive license agreement with Sebela for the global rights to Miudella ®2, a hormone-free copper intrauterine device ("IUD") that was approved by the …
SHANGHAI-HENLIUS-BIOTECH-INC SHANGHAI-HENLIUS-BIOTECH-INC 92% In the first quarter of 2026, in anticipation of the expected launch of HLX-11 in the United States, the Company entered into an agreement with Henlius that amended the terms of the existing license …
MRK Merck & Co., Inc. 90% Oss, Netherlands Women’s health Pandaan, Indonesia Cardiovascular, respiratory and dermatology Xochimilco, Mexico Cardiovascular and respiratory Most of our internal manufacturing sites have long-sta…
MRK Merck & Co., Inc. 90% Reciprocal relationship from MRK graph: Reciprocal relationship from OGN graph: Reciprocal relationship from MRK graph: Reciprocal relationship from OGN graph: Oss, Netherlands Women’s health Pandaan…
SAMSUNG-BIOEPIS-CO-LTD SAMSUNG-BIOEPIS-CO-LTD 90% The Company has an agreement with Samsung Bioepis Co., Ltd. ("Samsung Bioepis") to develop and commercialize multiple pre-specified biosimilar candidates, which have since launched and are part of th…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from OGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from OGN graph: Reciprocal relationship from JNJ graph:…
JNJ Johnson & Johnson 72% nd treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. Jada uses a low-level vacuum to encourage the physiologic contraction of the uterus to co…
ROIV Roivant Sciences Ltd. 72% Reciprocal relationship from ROIV graph: Reciprocal relationship from OGN graph: Reciprocal relationship from ROIV graph: of any renegotiated trade agreements, nor can we determine the impact they ma…

Organon & Co. Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from OGN graph: nd treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. Jada uses…
JNJ Johnson & Johnson 72% nd treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. Jada uses a low-level vacuum to encourage the physiologic contraction of the uterus to co…
MRK Merck & Co., Inc. 72% Reciprocal relationship from MRK graph: Reciprocal relationship from OGN graph: es allow us to execute customer engagement strategies optimized across preferred channels and aimed at healthcare provi…
MRK Merck & Co., Inc. 72% es allow us to execute customer engagement strategies optimized across preferred channels and aimed at healthcare providers, patients and payors. Our global and local marketing employees focus on bui…
ORANY ORANY 72% . All federal cases involving allegations of femur fractures have been transferred to a multidistrict litigation in the U.S. District Court for the District of New Jersey (“Femur Fracture MDL”). In t…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from OGN graph: . All federal cases involving allegations of femur fractures have been transferred to a multidistrict litigation in t…
ROIV Roivant Sciences Ltd. 72% Reciprocal relationship from ROIV graph: all, which could negatively affect our capacity for certain strategic transactions or our ability to make other important investments. In addition, high level…

Organon & Co. Debt Obligations

InstrumentDescriptionConfidenceEvidence
OGN-DEBT Debt stack $8.6B 90% Market cache reports total debt of $8.6B.

Organon & Co. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Organon & Co..

Organon & Co. Ownership

HolderNameConfidenceEvidence
OGN-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 623 tracked holders.

Organon & Co. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JNJ Johnson & Johnson 100.00 1 ['customer', 'supplier']
ROIV Roivant Sciences Ltd. 100.00 1 ['customer', 'supplier']
MRK Merck & Co., Inc. 100.00 1 ['customer', 'supplier']
ORANY ORANGE 100.00 1 ['customer']
CYCN Cyclerion Therapeutics, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
BLTE Belite Bio, Inc 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
CTMX CytomX Therapeutics, Inc. 50.00 2
ANIK Anika Therapeutics, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
EXOZ eXoZymes, Inc. 50.00 2
BNBX BNB Plus Corp. 50.00 2
CYTOF Altamira Therapeutics Ltd. 50.00 2
AVBP ArriVent BioPharma, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
AORT Artivion, Inc. 50.00 2